The Patient-Reported Outcome (PRO) Consortium: Filling Measurement Gaps for PRO End Points to Support Labeling Claims
Authors:
- 12 October 2011
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 90 (5) , 743-748
Abstract
The importance of appropriately and effectively incorporating the patient's voice into the evaluation of new medical products has been recognized and affirmed by regulators.(1,2,3) Patient-reported outcomes (PROs) are increasingly being assessed in clinical trials to quantify treatment benefits such as symptom relief and improved functioning. Translating PRO-based treatment benefits into labeling claims can provide information to physicians and patients and assist in prescribing decisions.(4,5) Hence, standardizing the valid and reliable measurement of PRO end points is critical.Keywords
This publication has 17 references indexed in Scilit:
- PHP97 PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PROS AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010Value in Health, 2011
- Adding The Patient Perspective To Comparative Effectiveness ResearchHealth Affairs, 2010
- Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force ReportValue in Health, 2009
- Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force ReportValue in Health, 2009
- Current Status of Patient-Reported Outcomes in Industry-Sponsored Oncology Clinical Trials and Product LabelsJournal of Clinical Oncology, 2007
- Patient-Reported Outcomes Supporting Anticancer Product ApprovalsJournal of Clinical Oncology, 2007
- Patient-Reported Outcomes: Instrument Development and Selection IssuesValue in Health, 2007
- Patient-Reported Outcome Instrument Selection: Designing a Measurement StrategyValue in Health, 2007
- Assessment of patient‐reported outcomes in clinical trials: the example of health‐related quality of lifeFundamental & Clinical Pharmacology, 2004
- Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory ProcessDrug Information Journal, 2002